uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis ; volume:9 ; number:1 ; day:5 ; month:12 ; year:2018 ; pages:1-16 ; date:12.2018
Nature Communications ; 9, Heft 1 (5.12.2018), 1-16, 12.2018
- Creator
-
Durré, Tania
Morfoisse, Florent
Erpicum, Charlotte
Ebroin, Marie
Blacher, Silvia
García-Caballero, Melissa
Deroanne, Christophe
Louis, Thomas
Balsat, Cédric
Van de Velde, Maureen
Kaijalainen, Seppo
Kridelka, Frédéric
Engelholm, Lars
Struman, Ingrid
Alitalo, Kari
Behrendt, Niels
Paupert, Jenny
Noel, Agnès
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-018-07514-1
- URN
-
urn:nbn:de:101:1-2019011916190270181043
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Durré, Tania
- Morfoisse, Florent
- Erpicum, Charlotte
- Ebroin, Marie
- Blacher, Silvia
- García-Caballero, Melissa
- Deroanne, Christophe
- Louis, Thomas
- Balsat, Cédric
- Van de Velde, Maureen
- Kaijalainen, Seppo
- Kridelka, Frédéric
- Engelholm, Lars
- Struman, Ingrid
- Alitalo, Kari
- Behrendt, Niels
- Paupert, Jenny
- Noel, Agnès
- SpringerLink (Online service)
Other Objects (12)
Regulation of lymphangiogenesis in the diaphragm by macrophages and VEGFR-3 signaling
Slit2N and Robo4 regulate lymphangiogenesis through the VEGF-C/VEGFR-3 pathway
Dual FGFR and VEGFR inhibition synergistically restrain hexokinase 2-dependent lymphangiogenesis and immune escape in intrahepatic cholangiocarcinoma
Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases
Vascular endothelial growth factor (VEGF)-C and its receptors, soluble VEGFR-2 and VEGFR-3, in polycystic ovary syndrome
Enhancement of cardiac lymphangiogenesis by transplantation of CD34+VEGFR-3+ endothelial progenitor cells and sustained release of VEGF-C
Counterbalance: modulation of VEGF/VEGFR activities by TNFSF15
Veränderung der Expression von VEGF, VEGFR-1, VEGFR-2, MMP12 und Rab23 in der Lunge von Patienten mit parenchymatösen Lungenerkrankungen
Der differentielle Einfluss der beiden VEGF-Rezeptoren VEGFR-1 und VEGFR-2 auf die Genexpression von PIGF und MCP-1
VEGF-A/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody
Correction: VEGF-A/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody
The molecular function of CD44v6 for the receptor tyrosine kinases Met and VEGFR-2
Regulation of lymphangiogenesis in the diaphragm by macrophages and VEGFR-3 signaling
Slit2N and Robo4 regulate lymphangiogenesis through the VEGF-C/VEGFR-3 pathway
Dual FGFR and VEGFR inhibition synergistically restrain hexokinase 2-dependent lymphangiogenesis and immune escape in intrahepatic cholangiocarcinoma
Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases
Vascular endothelial growth factor (VEGF)-C and its receptors, soluble VEGFR-2 and VEGFR-3, in polycystic ovary syndrome
Enhancement of cardiac lymphangiogenesis by transplantation of CD34+VEGFR-3+ endothelial progenitor cells and sustained release of VEGF-C
Counterbalance: modulation of VEGF/VEGFR activities by TNFSF15
Veränderung der Expression von VEGF, VEGFR-1, VEGFR-2, MMP12 und Rab23 in der Lunge von Patienten mit parenchymatösen Lungenerkrankungen
Der differentielle Einfluss der beiden VEGF-Rezeptoren VEGFR-1 und VEGFR-2 auf die Genexpression von PIGF und MCP-1
VEGF-A/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody
Correction: VEGF-A/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody
The molecular function of CD44v6 for the receptor tyrosine kinases Met and VEGFR-2
Regulation of lymphangiogenesis in the diaphragm by macrophages and VEGFR-3 signaling
Slit2N and Robo4 regulate lymphangiogenesis through the VEGF-C/VEGFR-3 pathway
Dual FGFR and VEGFR inhibition synergistically restrain hexokinase 2-dependent lymphangiogenesis and immune escape in intrahepatic cholangiocarcinoma
Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases
Vascular endothelial growth factor (VEGF)-C and its receptors, soluble VEGFR-2 and VEGFR-3, in polycystic ovary syndrome
Enhancement of cardiac lymphangiogenesis by transplantation of CD34+VEGFR-3+ endothelial progenitor cells and sustained release of VEGF-C
Counterbalance: modulation of VEGF/VEGFR activities by TNFSF15
Veränderung der Expression von VEGF, VEGFR-1, VEGFR-2, MMP12 und Rab23 in der Lunge von Patienten mit parenchymatösen Lungenerkrankungen
Der differentielle Einfluss der beiden VEGF-Rezeptoren VEGFR-1 und VEGFR-2 auf die Genexpression von PIGF und MCP-1
VEGF-A/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody
Correction: VEGF-A/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody